274 related articles for article (PubMed ID: 27002182)
21. Cantharimides: a new class of modified cantharidin analogues inhibiting protein phosphatases 1 and 2A.
McCluskey A; Walkom C; Bowyer MC; Ackland SP; Gardiner E; Sakoff JA
Bioorg Med Chem Lett; 2001 Nov; 11(22):2941-6. PubMed ID: 11677131
[TBL] [Abstract][Full Text] [Related]
22. Biochemical characterization and deletion analysis of recombinant human protein phosphatase 2C alpha.
Marley AE; Sullivan JE; Carling D; Abbott WM; Smith GJ; Taylor IW; Carey F; Beri RK
Biochem J; 1996 Dec; 320 ( Pt 3)(Pt 3):801-6. PubMed ID: 9003365
[TBL] [Abstract][Full Text] [Related]
23. Exploration of new drug-like inhibitors for serine/threonine protein phosphatase 5 of Plasmodium falciparum: a docking and simulation study.
Gupta S; Jadaun A; Kumar H; Raj U; Varadwaj PK; Rao AR
J Biomol Struct Dyn; 2015; 33(11):2421-41. PubMed ID: 25967133
[TBL] [Abstract][Full Text] [Related]
24. Characterization of the active site and a unique uncompetitive inhibitor of the PPM1-type protein phosphatase PPM1D.
Chuman Y; Yagi H; Fukuda T; Nomura T; Matsukizono M; Shimohigashi Y; Sakaguchi K
Protein Pept Lett; 2008; 15(9):938-48. PubMed ID: 18991770
[TBL] [Abstract][Full Text] [Related]
25. Structural and functional analysis of the phosphoryl transfer reaction mediated by the human small C-terminal domain phosphatase, Scp1.
Zhang M; Liu J; Kim Y; Dixon JE; Pfaff SL; Gill GN; Noel JP; Zhang Y
Protein Sci; 2010 May; 19(5):974-86. PubMed ID: 20222012
[TBL] [Abstract][Full Text] [Related]
26. Protein phosphatase 5 promotes hepatocarcinogenesis through interaction with AMP-activated protein kinase.
Chen YL; Hung MH; Chu PY; Chao TI; Tsai MH; Chen LJ; Hsiao YJ; Shih CT; Hsieh FS; Chen KF
Biochem Pharmacol; 2017 Aug; 138():49-60. PubMed ID: 28528695
[TBL] [Abstract][Full Text] [Related]
27. Exploiting protein phosphatase inhibitors based on cantharidin analogues for cancer drug discovery.
Deng L; Dong J; Wang W
Mini Rev Med Chem; 2013 Jun; 13(8):1166-76. PubMed ID: 23373656
[TBL] [Abstract][Full Text] [Related]
28. Structural studies of protein arginine methyltransferase 2 reveal its interactions with potential substrates and inhibitors.
Cura V; Marechal N; Troffer-Charlier N; Strub JM; van Haren MJ; Martin NI; Cianférani S; Bonnefond L; Cavarelli J
FEBS J; 2017 Jan; 284(1):77-96. PubMed ID: 27879050
[TBL] [Abstract][Full Text] [Related]
29. Structural analysis of the PP2C phosphatase tPphA from Thermosynechococcus elongatus: a flexible flap subdomain controls access to the catalytic site.
Schlicker C; Fokina O; Kloft N; Grüne T; Becker S; Sheldrick GM; Forchhammer K
J Mol Biol; 2008 Feb; 376(2):570-81. PubMed ID: 18164312
[TBL] [Abstract][Full Text] [Related]
30. Structural basis for regulation of protein phosphatase 1 by inhibitor-2.
Hurley TD; Yang J; Zhang L; Goodwin KD; Zou Q; Cortese M; Dunker AK; DePaoli-Roach AA
J Biol Chem; 2007 Sep; 282(39):28874-28883. PubMed ID: 17636256
[TBL] [Abstract][Full Text] [Related]
31. Active-site mutations impairing the catalytic function of the catalytic subunit of human protein phosphatase 2A permit baculovirus-mediated overexpression in insect cells.
Myles T; Schmidt K; Evans DR; Cron P; Hemmings BA
Biochem J; 2001 Jul; 357(Pt 1):225-32. PubMed ID: 11415453
[TBL] [Abstract][Full Text] [Related]
32. Structure of Saccharomyces cerevisiae Rtr1 reveals an active site for an atypical phosphatase.
Irani S; Yogesha SD; Mayfield J; Zhang M; Zhang Y; Matthews WL; Nie G; Prescott NA; Zhang YJ
Sci Signal; 2016 Mar; 9(417):ra24. PubMed ID: 26933063
[TBL] [Abstract][Full Text] [Related]
33. Cytotoxicity of cantharidin analogues targeting protein phosphatase 2A.
Shan HB; Cai YC; Liu Y; Zeng WN; Chen HX; Fan BT; Liu XH; Xu ZL; Wang B; Xian LJ
Anticancer Drugs; 2006 Sep; 17(8):905-11. PubMed ID: 16940800
[TBL] [Abstract][Full Text] [Related]
34. Norcantharidin analogues: synthesis, anticancer activity and protein phosphatase 1 and 2A inhibition.
Hill TA; Stewart SG; Gordon CP; Ackland SP; Gilbert J; Sauer B; Sakoff JA; McCluskey A
ChemMedChem; 2008 Dec; 3(12):1878-92. PubMed ID: 19025735
[TBL] [Abstract][Full Text] [Related]
35. Crystal structures of protein phosphatase-1 bound to nodularin-R and tautomycin: a novel scaffold for structure-based drug design of serine/threonine phosphatase inhibitors.
Kelker MS; Page R; Peti W
J Mol Biol; 2009 Jan; 385(1):11-21. PubMed ID: 18992256
[TBL] [Abstract][Full Text] [Related]
36. Focused library with a core structure extracted from natural products and modified: application to phosphatase inhibitors and several biochemical findings.
Hirai G; Sodeoka M
Acc Chem Res; 2015 May; 48(5):1464-73. PubMed ID: 25894598
[TBL] [Abstract][Full Text] [Related]
37. Identification of a Highly Conserved Hypothetical Protein TON_0340 as a Probable Manganese-Dependent Phosphatase.
Sohn YS; Lee SG; Lee KH; Ku B; Shin HC; Cha SS; Kim YG; Lee HS; Kang SG; Oh BH
PLoS One; 2016; 11(12):e0167549. PubMed ID: 27907125
[TBL] [Abstract][Full Text] [Related]
38. Antitumor potential of the protein phosphatase inhibitor, cantharidin, and selected derivatives.
Ren Y; Kinghorn AD
Bioorg Med Chem; 2021 Feb; 32():116012. PubMed ID: 33454654
[TBL] [Abstract][Full Text] [Related]
39. Structure-based design of a highly selective catalytic site-directed inhibitor of Ser/Thr protein phosphatase 2B (calcineurin).
Baba Y; Hirukawa N; Tanohira N; Sodeoka M
J Am Chem Soc; 2003 Aug; 125(32):9740-9. PubMed ID: 12904040
[TBL] [Abstract][Full Text] [Related]
40. Phosphorylase phosphatase: new horizons for an old enzyme.
Lee EY; Zhang L; Zhao S; Wei Q; Zhang J; Qi ZQ; Belmonte ER
Front Biosci; 1999 Mar; 4():D270-85. PubMed ID: 10077543
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
